retatrutide phase 3 triumph Michael Weintraub, MD on X: "Looking forward to when #retatrutide's trial results will become available. There are are 4 planned trials investigating retatrutide's efficacy in treating obesity and its Retatrutide Achieves Up to 28.7%

A primary care provider can review weight history, blood pressure, cholesterol, A1C, thyroid levels, kidney function, liver health, medications, sleep habits, diet patterns, and activity level

The 17mg/mL formulation is for higher doses (7.5mg to 15mg weekly) and keeps injection volumes smaller and more comfortable

M.EgleD.Mller-HolznerE.SchmidtS.et al (2012)

Cardiovascular Response (Unique to the Triple Agonist) : Retatrutides glucagon component stimulates the sympathetic nervous system, leading to a transient increase in resting heart rate during the early stages of titration (peaking around week 24 at a few extra beats per minute before gradually declining back to baseline)

Digital tools can make this even easier by automatically tracking your injection details

Call us at 417-881-4994 or email us at [email protected]